Almac Forms Academia-Industry Collaboration to Develop Green Chemicals
Almac announces its high level involvement in a synthetic biology project to develop novel routes to chemicals. Other partners in the academic–industry collaboration include Bangor University (Wales) and Hockley International (manufacturer and exporter of environmental health and industrial chemical products).
A grant of £1 million has been awarded to the research team by the Biotechnology & Biological Sciences Research Council and Technology Strategy Board. The funding is specifically targeted at bringing a novel chemical produced via an enzymatic route from under-utilised natural oil to the market.
Almac is currently performing the research and development work at its Northern Ireland-based laboratories. The company is partnering with scientific experts from both the University’s College of Natural Sciences and Hockley to progress the project over a three year period.
Professor Tom Moody, Head of Biocatalysis & Isotope Chemistry at Almac, commented: “Almac has cultivated considerable enzyme technology experience and expertise over the past decade and collaboration in this research is especially important for the development of green processes in this industry. Our expert team of scientists are excited to work on this project as we recognise the opportunity for researchers across industry and academia to work more closely together, sharing skills and knowledge to deliver truly excellent research that can make an impact not just on this project but also the UK. Indeed, we are delighted to be at the forefront of such partnerships.”
“It will form a close collaboration between Almac, Hockley and the University’s School of Biological Sciences, Biocomposites Centre,” explains Dr Viacheslav Tverezovskiy who is leading this research at Bangor University.
Frank Howard, MD and owner of Hockley International adds “We look forward to starting this major 3-year project in synthetic biology along with Almac and Bangor University which promises to be most exciting and scientifically challenging for us all.”
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance